Patents by Inventor Chuanmin SUN

Chuanmin SUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12110525
    Abstract: An R-3-aminobutyric acid preparation method with high efficiency and high stereoselectivity. The method comprises using aspartase with stereoisomerization catalytic activity derived from Escherichia coli to efficiently convert butenoic acid into R-3-aminobutyric acid. After only 24 h of reaction, the conversion rate is as high as ?98%, and the ee value is ?99.9%. The conversion efficiency is greatly improved, the reaction time is shortened, and the production costs are reduced. The method features a high yield, a high conversion rate, low costs, a short production cycle, a simple process, ease of enlargement, suitability for mass production and the like.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: October 8, 2024
    Assignee: ABIOCHEM BIOTECHNOLOGY (GROUP) CO., LTD.
    Inventors: Chuanmin Sun, Zhanbing Cheng, Jianghua Jiao, Shaonan Ding, Zhenhua Tian
  • Patent number: 11492607
    Abstract: The invention provides a highly active S-cyanohydrin lyase obtained by mutating an amino acid residue at position 103 of a wild-type cassava S-cyanohydrin lyase. The mutation can significantly increase an expression of a mutant enzyme in E. coli and does not require a decrease in temperature when induced. Further mutations at position 128 and other sites were performed to obtain mutants with increased catalytic activity.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: November 8, 2022
    Assignee: ABIOCHEM BIOTECHNOLOGY CO., LTD.
    Inventors: Zhenhua Tian, Zhanbing Cheng, Chuanmin Sun
  • Publication number: 20220090152
    Abstract: An R-3-aminobutyric acid preparation method with high efficiency and high stereoselectivity. The method comprises using aspartase with stereoisomerization catalytic activity derived from Escherichia coli to efficiently convert butenoic acid into R-3-aminobutyric acid. After only 24 h of reaction, the conversion rate is as high as ?98%, and the ee value is ?99.9%. The conversion efficiency is greatly improved, the reaction time is shortened, and the production costs are reduced. The method features a high yield, a high conversion rate, low costs, a short production cycle, a simple process, ease of enlargement, suitability for mass production and the like.
    Type: Application
    Filed: December 1, 2021
    Publication date: March 24, 2022
    Applicant: ABIOCHEM BIOTECHNOLOGY CO., LTD.
    Inventors: Chuanmin SUN, Zhanbing CHENG, Jianghua JIAO, Shaonan DING, Zhenhua TIAN
  • Patent number: 11220701
    Abstract: An R-3-aminobutyric acid preparation method with high efficiency and high stereoselectivity. The method comprises using aspartase with stereoisomerization catalytic activity derived from Escherichia coli to efficiently convert butenoic acid into R-3-aminobutyric acid. After only 24 h of reaction, the conversion rate is as high as ?98%, and the ee value is ?99.9%. The conversion efficiency is greatly improved, the reaction time is shortened, and the production costs are reduced. The method features a high yield, a high conversion rate, low costs, a short production cycle, a simple process, ease of enlargement, suitability for mass production and the like.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: January 11, 2022
    Assignee: ABIOCHEM BIOTECHNOLOGY CO., LTD.
    Inventors: Chuanmin Sun, Zhanbing Cheng, Jianghua Jiao, Shaonan Ding, Zhenhua Tian
  • Publication number: 20210403893
    Abstract: The invention provides a highly active S-cyanohydrin lyase obtained by mutating an amino acid residue at position 103 of a wild-type cassava S-cyanohydrin lyase. The mutation can significantly increase an expression of a mutant enzyme in E. coli and does not require a decrease in temperature when induced. Further mutations at position 128 and other sites were performed to obtain mutants with increased catalytic activity.
    Type: Application
    Filed: January 5, 2018
    Publication date: December 30, 2021
    Applicant: Abiochem Biotechnology Co., Ltd.
    Inventors: Zhenhua TIAN, Zhanbing CHENG, Chuanmin SUN
  • Publication number: 20200384003
    Abstract: The present invention relates to a novel use of a triterpenoid. In particular, the present invention provides a use of a compound of formula I, or an optical isomer thereof, or a racemate thereof, or a solvate thereof, or a pharmaceutically acceptable salt thereof, or a prodrug thereof in the preparation of a pharmaceutical composition or a preparation for preventing and/or treating ocular diseases caused by crystalline lens lesions. A novel finding of the present invention is that the compound of formula I can prevent and/or treat ocular diseases caused by crystalline lens lesions, such as prevention and treatment of cataracts, is safe, has low toxicity and few side effects, and has remarkable therapeutic efficacy and development and application prospects.
    Type: Application
    Filed: December 28, 2018
    Publication date: December 10, 2020
    Inventors: Qinyuan ZHENG, Jingjie ZHU, Jing QU, Yu LUO, Shicheng DING, Lijun QIN, Xiangyan ZHOU, Chuanmin SUN, Fenqin ZHAO, Cunqing ZHANG, Zhongwei JI, Li GUO
  • Publication number: 20200232002
    Abstract: An R-3-aminobutyric acid preparation method with high efficiency and high stereoselectivity. The method comprises using aspartase with stereoisomerization catalytic activity derived from Escherichia coli to efficiently convert butenoic acid into R-3-aminobutyric acid. After only 24 h of reaction, the conversion rate is as high as ?98%, and the ee value is ?99.9%. The conversion efficiency is greatly improved, the reaction time is shortened, and the production costs are reduced. The method features a high yield, a high conversion rate, low costs, a short production cycle, a simple process, ease of enlargement, suitability for mass production and the like.
    Type: Application
    Filed: June 20, 2018
    Publication date: July 23, 2020
    Applicant: ABIOCHEM BIOTECHNOLOGY CO., LTD.
    Inventors: Chuanmin SUN, Zhanbing CHENG, Jianghua JIAO, Shaonan DING, Zhenhua TIAN